Completed NA INTERVENTIONAL 7-arm NCT02894892

Intragastric pH and Bismuth Effect for H. Pylori Eradication

Sponsor: Ministry of Science and Technology, Taiwan

Conditions Helicobacter Pylori Infection

Interventions (A)Bismuth (B)Bismuth (C)Bismuth (D)Esomeprazole and Bismuth (E)Esomeprazole and Bismuth (F)Esomeprazole and Bismuth (G)Control

Updated 7 times since 2017 Last updated: May 30, 2019 Started: Nov 15, 2016 Primary completion: Oct 18, 2017 Completion: Feb 20, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Helicobacter Pylori Infection and is currently completed. Ministry of Science and Technology, Taiwan leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Jun 2025 — Present [monthly]

Completed NA
Sep 2024 — Jun 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jul 2019 — Jan 2021 [monthly]

Completed NA

Status: Not Yet Recruiting → Completed · Phase: PHASE4 → NA

▶ Show 2 earlier versions

Jun 2018 — Jul 2019 [monthly]

Not Yet Recruiting PHASE4
Jan 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ministry of Science and Technology, Taiwan
National Taiwan University Hospital

Data source: National Taiwan University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan